Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai Inc (NASDAQ: MRAI) delivers AI-powered Third-Party Administration services for self-funded health plans, combining deep learning with healthcare cost management. This news hub provides investors and benefits professionals with essential updates on the company's operational developments and strategic initiatives.
Access comprehensive coverage of Marpai's financial announcements, technology advancements, and partnership updates. Our curated news collection features press releases detailing cost-containment programs, artificial intelligence implementations, and service expansions within the $22 billion TPA market.
Key updates include earnings reports, leadership changes, predictive analytics breakthroughs, and network expansions. The repository serves as a centralized source for tracking Marpai's progress in reducing employer healthcare costs through machine learning applications and operational optimizations.
Bookmark this page for real-time updates on Marpai's initiatives in healthcare AI and benefits administration. Regularly refreshed content ensures stakeholders maintain current understanding of the company's market position and technological innovations in the evolving TPA sector.
Marpai (OTCQX: MRAI) released its Q1 2025 financial results, showing mixed performance with significant cost reductions but lower revenue. The company reported net revenues of $5.4 million, down 27% year-over-year, while successfully reducing operating expenses by 33% to $7.7 million. The operating loss improved by 45% to $2.3 million, and net loss decreased by 29% to $3.1 million.
CEO Damien Lamendola highlighted upcoming initiatives including the launch of a Healthcare Management tool with Empara, advancements in MarpaiRx, and the onboarding of new COO Dallas Scrip. The company aims to achieve profitability and positive cash flow by the end of 2025. Marpai ended Q1 with $0.7 million in unrestricted cash, slightly down from the previous year.
Marpai (OTCQX: MRAI), a healthcare technology and Third-Party Administration (TPA) services provider, has appointed Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. Scrip brings extensive experience in scaling private equity and venture capital-owned companies, with expertise in healthcare consumer services, employers, providers, and payor markets.
The strategic hire aims to accelerate Marpai's profitable growth and enhance operational excellence. CEO Damien Lamendola emphasized that Scrip's appointment is crucial for the company's journey towards sustainable growth, citing his proven track record in complex healthcare environments and deep understanding of the TPA landscape.
Marpai Inc. (OTCQX: MRAI), a healthcare technology and Third-Party Administration (TPA) services provider, has scheduled its Q1 2025 earnings conference call for May 15, 2025, at 8:30 a.m. ET. The company will release its first quarter 2025 financial results on Wednesday, May 14, after market close.
The conference call will be accessible via phone (US: 1-646-357-8785 / Toll Free: 1-800-836-8184) and webcast. A replay will be available at the same webcast URL within 2 hours after the call ends and will remain accessible until May 22, 2025. The telephonic replay can be accessed using the code 37963#.
Marpai Inc (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA) for self-funded employer health plans, has announced its participation in the Planet MicroCap Showcase: VEGAS 2025.
The company's presentation is scheduled for Wednesday, April 23, 2025, at 5:30 PM PST. CEO Damien Lamendola and CFO Steve Johnson will lead the presentation and conduct a Q&A session. The event will be held at the Paris Hotel & Casino in Las Vegas, NV.
Investors can attend the live presentation through a webcast and schedule one-on-one meetings with Marpai's management on Thursday, April 24, 2025. The conference is being organized in partnership with MicroCapClub, and registration is required for both the presentation and individual meetings.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), announced its Q4 and full year 2024 financial results. Q4 2024 showed mixed results with net revenues of $6.6M (6% decrease from Q3), while net loss improved by 67.5% year-over-year to $1.2M.
For Full Year 2024, the company reported net revenues of $28.2M (24.2% decrease YoY), but demonstrated significant improvements in losses. Operating loss decreased by 21.1% to $22.1M, while Adjusted EBITDA loss improved to $9.1M from $20.2M in 2023.
CEO Damien Lamendola highlighted the company's turnaround efforts, announcing plans to introduce PBM-based products in H2 2025. The company aims to achieve profitability in 2025 through continued cost streamlining and innovative services like the Empara Member Engagement Portal.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has announced it will host a conference call and webcast on March 27, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results.
The company, which aims to transform the $22 billion TPA market through affordable, intelligent healthcare solutions for self-funded employer health plans, will release its Q4 and full year 2024 results on Wednesday after market close. A webcast replay will be available at the same URL within 2 hours of the call's conclusion and accessible until April 3, 2025.
Marpai (OTCQX: MRAI), a technology platform company in the $22 billion Third-Party Administrator market, has announced a strategic collaboration with Empara to transform self-funded employer health plans. The partnership includes the immediate implementation of Empara's Health Engagement Platform.
The new unified platform will consolidate multiple fragmented tools, apps, and portals into a streamlined solution featuring a member app, partner console, and marketplace. The integration aims to enhance benefit utilization and cost control while improving user experience for plan members and administrators.
According to John Powers, Marpai's President, the full platform is expected to be operational by the end of Q2 2025, marking a significant step in the company's TPA evolution.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has secured an additional $5 million in non-dilutive funding from JGB Collateral This follows their previous agreement from April 16, 2024, where they sold Senior Secured Convertible Debentures worth $11.83 million for $11 million.
Of the new $5 million funding, $2 million was delivered at closing, with the remaining $3 million held in escrow pending certain conditions. Unlike the original investment, the conversion feature does not apply to these new debentures. The company plans to use the proceeds for growth initiatives and working capital. ThinkEquity served as an advisor for this financing.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has announced the pricing of a $700,000 private placement. The offering consists of 621,194 shares of Class A common stock at $1.13 per share, for total gross proceeds of $701,950. The investors include an institutional fund and company officers and directors. The closing is expected by December 6, 2024.
The company plans to use the net proceeds for general working capital. The securities are exempt from registration requirements under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Marpai, a technology platform company operating as a national Third-Party Administrator (TPA), has announced several key developments for Q4. The company has secured major new clients for 2025, including a 4,000-employee restaurant group, a 6,000-employee hospital group, and housing industry clients with approximately 3,400 employees. Marpai, which operates in the $22 billion TPA market, remains on track for expected break-even performance in early 2025, supported by these new sales and ongoing efficiency improvements.
FAQ
What is the current stock price of Marpai (MRAI)?
What is the market cap of Marpai (MRAI)?
